Portopulmonary hypertension echocardiography or ultrasound: Difference between revisions
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Portopulmonary hypertension}} | {{Portopulmonary hypertension}} | ||
{{CMG}} | {{CMG}};{{AE}} | ||
{{PleaseHelp}} | |||
==Overview== | ==Overview== | ||
==Echocardiography== | ==Echocardiography== | ||
The diagnosis of portopulmonary hypertension is based on hemodynamic criteria: | The diagnosis of portopulmonary hypertension is based on hemodynamic criteria: | ||
| Line 15: | Line 18: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 18:29, 18 July 2016
|
Portopulmonary hypertension Microchapters |
|
Differentiating Portopulmonary hypertension from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Portopulmonary hypertension echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Portopulmonary hypertension echocardiography or ultrasound |
|
FDA on Portopulmonary hypertension echocardiography or ultrasound |
|
CDC on Portopulmonary hypertension echocardiography or ultrasound |
|
Portopulmonary hypertension echocardiography or ultrasound in the news |
|
Blogs on Portopulmonary hypertension echocardiography or ultrasound |
|
Directions to Hospitals Treating Portopulmonary hypertension |
|
Risk calculators and risk factors for Portopulmonary hypertension echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Echocardiography
The diagnosis of portopulmonary hypertension is based on hemodynamic criteria:
- . Portal hypertension and/or liver disease (clinical diagnosis—ascites/varices/splenomegaly)
- . Mean pulmonary artery pressure—MPAP > 25 mmHg at rest
- . Pulmonary vascular resistance—PVR > 240 dynes s cm−5
- . Pulmonary artery occlusion pressure— PAOP < 15mmHg or transpulmonary gradient—TPG > 12 mmHg where TPG = MPAP − PAOP.[1]
The diagnosis is usually first suggested by a transthoracic echocardiogram, part of the standard pre-transplantation work-up. Echocardiogram estimated pulmonary artery systolic pressures of 40 to 50 mm Hg are used as a screening cutoff for PPH diagnosis,[2] with a sensitivity of 100% and a specificity as high as 96%. The negative predictive value of this method is 100% but the positive predictive value is 60%.[3]
References
- ↑ Swanson KL et al. Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups. Am J Transpl 2008; 8: 2445–2453
- ↑ Torregosa et al. Role of Doppler echos in the assessment of PPHTN in liver transplant candidates. Transplantation 2001;71:572-574
- ↑ Colle et al. Diagnosis of portopulmonary hypertension in candidates for liver transplant: a prospective study. Hepatology 2003;37:401-209